openPR Logo
Press release

School children does Gandhigiri with ITC

05-27-2011 11:11 AM CET | Health & Medicine

Press release from: Dharamshila Hospital and Research Centre

Cancer Hospital India

Cancer Hospital India

Gurgaon, May 27, 2011: On eve of “World No Tobacco Day” children from various schools in NCR region gathered in front of ITC Green Centre to urge Indian Tobacco Company (better known as ITC, India largest manufacturer of cigarette and also consumer brands like Ashirwad, Sunfeast, Minto, Bingo Chips) to stop making cigarettes which result in more than 700,000(7 lacs deaths every year).

The children carried Gandhigiri by showing the gathering ills of smoking through a 10 feet high cigarette memento (Largest ever to be made in Asia), giving a 8 feet long signed graffiti for Yogi Deveshwar, Chairman of ITC, by observing silence for 2 minutes in memory of those who have died due to smoking and putting black ribbon on their lips as a token of protest.

Commenting on the silent protest, Pankaj Sharma, Chief Trustee, Centre for Transforming India stated that due to smoking and other forms of tobacco consumption more than 10 lac people die every year. For every rupee earned by the industry the government has to spent at least five as additional healthcare burden besides a massive loss of life . This silent protest of children to save their future from this demon called smoking is indeed a commendable effort to shake the soul of organizations for whom profit motive matters more than even human life.

The event witnessed a huge turnaround of people from all sections of society and was supported by Dharamshila Hospital and Research Centre, which is India’s leading Cancer Research Institute.

About Dharamshila Hospital And Research Centre

Dharamshila Hospital And Research Centre, a leading Cancer Hospital of India, for advanced cancer treatment. It is the largest cancer hospital in Delhi with bed strength of 300. Dharamshila Hospital And Research Centre (DHRC) is India's First and only NABH accredited Cancer hospital with NABL Accredited labs, which is the testimony to the aforesaid fact.

Keeping afoot with its tradition of “patient first” policies, the hospital is successfully treating patients from across the globe not only for cancer but also for other specialities / superspecialities such as General Medicine, General and laparoscopic surgery, Pulmonology, Gastroenterology, G. I. Surgeries, Nephrology, Urology, Neurology, Neurosurgery, Plastic and Reconstructive Surgery, Otorihnolaryngology, Dental and Facio-maxillary Surgery, Dermatology, Paediatrics, Paediatric Surgery, Plastic Surgery, Orthopaedic Surgery etc. to name a few.

Backed By State-of-the-art medical equipments and latest technology – DHRC helps detect cancer at an early stage thus saving time, money and most importantly life of a patient, which has attracted patients from USA, Australia, Netherlands, Yaman, Sudan, Nepal, Bangladesh, Iraq, Afghanistan, Nigeria and Iran. DHRC has been successfully living up to the expectations of these patients.

Dharamshila Hospital has the first hand experience of seeing the damage caused by the use of tobacco (Active smoking, Passive Smoking, Chewing Tobacco). Sixty percent of the patients reporting at Dharamshila Hospital are suffering from Cancers of the lungs, mouth (gum, tongue, cheek, nasopharynx) and larynx (voice box) esophagus. Eighty percent of the Cancer patients reporting to Dharamshila Hospital are inoperable. However patients reporting at early stages are being operated and have a very high probability of disease free survival. Dharamshila’s proactive initiatives on Cancer awareness, early cancer detection and tobacco cessation clinics have helped them to downstage the Cancer as well as help people to quit tobacco.

Dharamshila Hospital And Research Centre, a leading Cancer Hospital of India, for advanced cancer treatment. It is the largest cancer hospital in Delhi with bed strength of 300. Dharamshila Hospital And Research Centre (DHRC) is India's First and only NABH accredited Cancer hospital with NABL Accredited labs, which is the testimony to the aforesaid fact.

Dharamshila Hospital and Research Centre
Dharamshila Marg, Vasundhara Enclave
Delhi - 110096, INDIA
Email- webmarketing@dhrc.in
Website - http://www.dhrc.in

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release School children does Gandhigiri with ITC here

News-ID: 176976 • Views:

More Releases from Dharamshila Hospital and Research Centre

Haplo-Identical Bone Marrow Transplantation, “The Glass is Always Half Full”
Haplo-Identical Bone Marrow Transplantation, “The Glass is Always Half Full”
A 25 year old IT professional was struck with Hodgkin ’s disease which is one of the most curable cancers. He was treated with standard chemotherapy and the disease went away only to reappear a few months later. This time he received local radiation and Autologous Bone Marrow Transplantation (BMT). However, the response was shortlived and the cancer sprung its ugly head within 6 months. The young man and his distraught
Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre
Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre
Eminent Healthcare Expert Dr Sandeep Chatrath receives the prestigious India’s Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre ILc Power Brand 2014. Dr Sandeep Chatrath also declared by the Jury as the CEO of the Year Healthcare 2014 at Asia’s Biggest Leadership Event, the 5th Annual India Leadership Conclave 2014 The prestigious & coveted Awards were presented in a glittering award ceremony

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top